Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
2005 1
2006 2
2007 4
2008 2
2009 3
2010 3
2011 5
2012 2
2013 1
2014 1
2015 2
2016 1
2017 2
2018 1
2019 1
2020 3
2021 6
2022 7
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM; TRAILBLAZER-ALZ 2 Investigators. Sims JR, et al. JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239. JAMA. 2023. PMID: 37459141 Free PMC article.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Niche-derived soluble DLK1 promotes glioma growth.
Grassi ES, Jeannot P, Pantazopoulou V, Berg TJ, Pietras A. Grassi ES, et al. Among authors: pietras a. Neoplasia. 2020 Dec;22(12):689-701. doi: 10.1016/j.neo.2020.10.005. Epub 2020 Oct 23. Neoplasia. 2020. PMID: 33142235 Free PMC article.
Cancer stem cells in tumor heterogeneity.
Pietras A. Pietras A. Adv Cancer Res. 2011;112:255-81. doi: 10.1016/B978-0-12-387688-1.00009-0. Adv Cancer Res. 2011. PMID: 21925307 Review.
Arsenic trioxide and neuroblastoma cytotoxicity.
Pettersson HM, Karlsson J, Pietras A, Øra I, Påhlman S. Pettersson HM, et al. Among authors: pietras a. J Bioenerg Biomembr. 2007 Feb;39(1):35-41. doi: 10.1007/s10863-006-9058-6. J Bioenerg Biomembr. 2007. PMID: 17549641 Review.
51 results